- Canton Citizen: “Orchard Cove awards 12 scholarships to staff” (Aug. 29, 2024, page 5)
- Veterinary Advantage: “Weekly Companion Animal News: August 19, 2024: Akston Biosciences and Purdue to partner for dog cancer drug development” (Aug. 19, 2024)
- Purdue News: “Purdue and Akston Biosciences Sign Partnership Agreement for Dog Cancer Drug Development” (Aug. 16, 2024)
- Purdue Innovates: “. @LifeAtPurdue and Akston Biosciences have joined forces to develop a cancer treatment for dogs. Learn more about the underlying tech developed at @pucvm and the @PUCancerInst : https://bit.ly/4dBYrS2″ (Aug. 16, 2024)
-
- AgriNovus Indiana (via X/Twitter): “Purdue University + Akston Biosciences partner to develop a dog cancer drug treatment” (Aug. 16, 2024)
- DVM360: “Wrap up: FDA confirms Purina pet food safety, and other news August 16, 2024 By dvm360 Staff News Article” (Aug. 16, 2024)
- DVM360: “Animal therapeutics company names partner for oncology drug development” (Aug. 15, 2024)
- HealthCare International: “Akston Biosciences, Purdue U. partner on cancer treatment for dogs” (Aug. 14, 2024)
- Drugs.com: “Prota Therapeutics Announces Publication In Allergy Of Long-Term Peanut Allergy Study Confirming Clinical Remission As The Optimal Treatment Outcome” (Aug. 14, 2024)
- FirstWord Pharma: “Prota Therapeutics Announces Publication in Allergy of Long-Term Peanut Allergy Study Confirming Clinical Remission as the Optimal Treatment Outcome” (Aug. 14, 2024)
- Drug Patent Watch: “Prota Therapeutics Announces Publication in Allergy of Long-Term Peanut Allergy Study Confirming Clinical Remission as the Optimal Treatment Outcome” (Aug. 14, 2024)
- Biotech Gate: “Prota Therapeutics Announces Publication in Allergy of Long-Term Peanut Allergy Study Confirming Clinical Remission as the Optimal Treatment Outcome: Results affirm the advantages of Prota’s remission peanut OIT treatments, which lead to significant and sustained benefits including substantially improved Health Related Quality of Life” (Aug. 14, 2024)
- Drug Development & Delivery: “Prota Therapeutics Announces Publication In Allergy Of Long-Term Peanut Allergy Study Confirming Clinical Remission As The Optimal Treatment Outcome” (Aug. 14, 2024)
- Morningstar: “Prota Therapeutics Announces Publication In Allergy Of Long-Term Peanut Allergy Study Confirming Clinical Remission As The Optimal Treatment Outcome” (Aug. 14, 2024)
- Banzinga: “Prota Therapeutics Announces Publication In Allergy Of Long-Term Peanut Allergy Study Confirming Clinical Remission As The Optimal Treatment Outcome” (Aug. 14, 2024)
- ADVFN: “Prota Therapeutics Announces Publication In Allergy Of Long-Term Peanut Allergy Study Confirming Clinical Remission As The Optimal Treatment Outcome” (Aug. 14, 2024)
- MENAFN: “Prota Therapeutics Announces Publication In Allergy Of Long-Term Peanut Allergy Study Confirming Clinical Remission As The Optimal Treatment Outcome” (Aug. 14, 2024)
- PharmaShots (via X/Twitter): “Akston Biosciences Collaborates with Purdue University to Co-Develop Immunotherapy for Cancer Treatment in Dogs #akstonbiosciences #purdue #anticpdl1mab #bladdercancer #animalhealth #companiondogs #monoclonalantibody #collaboration #cdmo https://pharmashots.com/18717/akston-biosciences-collaborates-with-purdue-university-to-co-develop-immunotherapy-for-cancer-treatment-in-dogs” (Aug. 14, 2024)
- PharmaShots: “Akston Biosciences Collaborates with Purdue University to Co-Develop Immunotherapy for Cancer Treatment in Dogs” (Aug. 14, 2024)
- Boston Business Journal (via X/Twitter): “Akston Biosciences Corp. is working with Purdue University to co-develop an immunotherapy to treat cancer in dogs” (Aug. 14, 2024)
- Teddy Kokoros (via X/Twitter): “Akston Biosciences Corp. is working with Purdue University to co-develop an immunotherapy to treat cancer in dogs” (Aug. 13, 2024)
- Boston Business Journal: “Akston Biosciences, Purdue U. partner on cancer treatment for dogs” (Aug. 13, 2024)
- VBDATA.cn (China): “普渡大学和阿克斯顿生物科学公司签署狗癌症药物开发合作协议: Purdue University and Axton Biosciences sign partnership agreement for dog cancer drug development” (Aug. 13, 2024)
- Yahoo! Finance: “Purdue and Akston Biosciences Sign Partnership Agreement for Dog Cancer Drug Development” (Aug. 13, 2024)
- Yahoo! Finance Singapore: “Purdue and Akston Biosciences Sign Partnership Agreement for Dog Cancer Drug Development” (Aug. 13, 2024)
- Street Insider: “Purdue and Akston Biosciences Sign Partnership Agreement for Dog Cancer Drug Development” (Aug. 13, 2024)
- Fuerza 94.3 FM: “Akston Biosciences, Purdue U. partner on cancer treatment for dogs” (Aug. 13, 2024)
- FOX 40: “Purdue and Akston Biosciences Sign Partnership Agreement for Dog Cancer Drug Development” (Aug. 13, 2024)
- Deer Park Tribune: “Purdue and Akston Biosciences Sign Partnership Agreement for Dog Cancer Drug Development” (Aug. 13, 2024)
- Morningstar: “Purdue and Akston Biosciences Sign Partnership Agreement for Dog Cancer Drug Development” (Aug. 13, 2024)
- Benzinga: “Purdue and Akston Biosciences Sign Partnership Agreement for Dog Cancer Drug Development” (Aug. 13, 2024)
- Business Insurance: “Purdue and Akston Biosciences Sign Partnership Agreement for Dog Cancer Drug Development” (Aug. 13, 2024)
- Minyanville: “Purdue and Akston Biosciences Sign Partnership Agreement for Dog Cancer Drug Development” (Aug. 13, 2024)
- Silicon Investor: “Purdue and Akston Biosciences Sign Partnership Agreement for Dog Cancer Drug Development” (Aug. 13, 2024)
- Metro Latino USA: “Purdue and Akston Biosciences Sign Partnership Agreement for Dog Cancer Drug Development” (Aug. 13, 2024)
- Blockchain Domain: “Purdue and Akston Biosciences Sign Partnership Agreement for Dog Cancer Drug Development” (Aug. 13, 2024)
- VidayExito: “What is the ideal temperature for sleeping at night and resting?” (Aug. 6, 2024)
- SciTechDaily: “Boost Your Workout: Scientists Have Discovered a New Treatment for Fatigue Caused by Exercise” (Aug. 5, 2024)
- Science News: “Boost Your Workout Scientists Have Discovered a New Treatment for Fatigue Caused by Exercise” (Aug. 5, 2024)
- Today’s Veterinary Business: “Dechra Takes Over Akston’s Insulin Program” (Aug. 5, 2024)
- Sharon Community TV: “Sharon Helps: Home Care & Hospice, Hebrew SeniorLife” (Aug. 5, 2024)
- Brakke Newsletter: “Dechra and Akston Biosciences Corporation announced Dechra’s purchase of all Akston’s interests in the companies’ dog and cat long-acting insulin programs” (Aug. 2, 2024)
- Sky News: “Scientists Have Discovered a New Treatment for Fatigue Caused by Exercise” (Aug. 1, 2024)
